Alligator Bioscience AB (publ) (STO:ATORX)
Sweden · Delayed Price · Currency is SEK 0.1934
+0.0112 (6.15%)
Mar 4, 2026, 5:17 PM CET
Alligator Bioscience AB Market Cap
Alligator Bioscience AB has a market cap or net worth of 103.38 million as of March 4, 2026. Its market cap has increased by 259.03% in one year.
Market Cap
103.38M
Enterprise Value
75.98M
Revenue
4.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.19
Market Cap Chart
Since November 23, 2016, Alligator Bioscience AB's market cap has decreased from 2.67B to 103.38M, a decrease of -96.12%. That is a compound annual growth rate of -29.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 97.39M | 559.78% |
| Dec 30, 2025 | 14.76M | -92.20% |
| Dec 30, 2024 | 189.17M | -58.27% |
| Dec 29, 2023 | 453.33M | 32.59% |
| Dec 30, 2022 | 341.91M | -39.69% |
| Dec 30, 2021 | 566.90M | -0.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NextCell Pharma AB | 150.38M |
| Active Biotech AB | 137.34M |
| IRLAB Therapeutics AB | 131.82M |
| Simris Group AB (PUBL) | 128.23M |
| Xbrane Biopharma AB | 127.86M |
| Annexin Pharmaceuticals AB | 110.12M |
| Biovica International AB | 109.47M |
| Biosergen AB | 90.17M |